Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IONIC RARE EARTHS LIMITED Director's Dealing 2017

Aug 17, 2017

65151_rns_2017-08-17_07a2c0ff-4148-44de-b5c5-ba70a0e1433e.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Appendix 3Y

Change of Director’s Interest Notice

Name of entity ORO VERDE LIMITED ABN 84 083 646 477

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director DR WOLF GERHARD MARTINICK
Date of last notice 20 June 2017

Part 1 - Change of director’s relevant interests in securities

Direct or indirect interest Direct
Nature of indirect interest Dr Martinick is a director of Martinick
(including registered holder) Investments Pty Ltd and a beneficiary of the
Martinick Superannuation Fund of which
Martinick Investments is a trustee
Date of change 17 August 2017
No. of securities held prior to change Direct – 8,194,339
Indirect - 43,000,000 fully paid shares
Class Fully paid ordinary shares
Number acquired 349,315
Number disposed -
Value/Consideration $5,100
No. of securities held after change Direct – 8,534,654
Indirect - 43,000,000 fully paid shares
Nature of changes Participation in the Company’s Directors
Share Plan approved by shareholders at the
2016 AGM

Part 2 – Change of director’s interests in contracts

NIL

Part 3 – Closed period

NILPart 3 – Closed period
Were the interests in the securities or contracts detailed No
above traded during a closed period where prior written
clearance was required?
If so, was prior written clearance provided to allow the trade N/A
to proceed during this period?
If prior written clearance was provided, on what date was this N/A
provided?